-+ 0.00%
-+ 0.00%
-+ 0.00%

ARVINAS JOINS THE MICHAEL J. FOX FOUNDATION’S LITE AND PPMI PROGRAMS TO ADVANCE NEW THERAPIES TARGETING LRRK2 FOR PARKINSON’S DISEASE

Reuters·06/04/2026 12:00:04

Please log in to view news